(HYGI) iShares U.S. Trust - - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US46431W5498 • High Yield Bond
HYGI: Bond, ETF, High-Yield, Inflation, Hedged
The iShares U.S. ETF Trust - iShares Inflation Hedged High Yield Bond ETF (HYGI) is designed to mitigate inflation risk in portfolios by focusing on U.S. dollar-denominated high-yield corporate bonds. The fund seeks to achieve its objective by primarily investing in high-yield bonds, with at least 80% of its net assets allocated to securities and instruments from its underlying index. This strategy aims to provide exposure to higher-yielding debt instruments while addressing inflation-related risks. The ETF is non-diversified, meaning it can concentrate its holdings in a smaller number of securities.
From a technical standpoint, HYGI has shown relative stability, with its SMA 20 at 26.94 and SMA 50 at 26.73, indicating a slight upward trend in recent months. The SMA 200 at 25.96 suggests longer-term growth potential. The Average True Range (ATR) of 0.09 reflects low volatility, making it a relatively stable investment option. The fund currently has an average daily trading volume of 2,400 shares, with a last price of 26.80. Its assets under management (AUM) stand at $5.41 million, indicating a smaller but focused portfolio.
Over the next three months, HYGI is expected to maintain its stable performance, supported by its low volatility and targeted investment strategy. The funds ability to hedge against inflation risk positions it well amid economic uncertainty. However, its smaller AUM and lower trading volume may limit liquidity, which could impact short-term price movements. Investors seeking exposure to high-yield bonds with inflation protection may find HYGI an attractive option, though they should monitor its liquidity and market conditions closely.
Additional Sources for HYGI ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
HYGI ETF Overview
Market Cap in USD | 5m |
Category | High Yield Bond |
TER | 0.52% |
IPO / Inception | 2022-06-22 |
HYGI ETF Ratings
Growth 5y | 59.5% |
Fundamental | - |
Dividend | 68.5% |
Rel. Strength Industry | 8.33 |
Analysts | - |
Fair Price Momentum | 27.22 USD |
Fair Price DCF | - |
HYGI Dividends
Dividend Yield 12m | 5.68% |
Yield on Cost 5y | 6.94% |
Annual Growth 5y | 27.05% |
Payout Consistency | 100.0% |
HYGI Growth Ratios
Growth Correlation 3m | 83.3% |
Growth Correlation 12m | 98.2% |
Growth Correlation 5y | 96.8% |
CAGR 5y | 8.40% |
CAGR/Max DD 5y | 0.87 |
Sharpe Ratio 12m | 2.23 |
Alpha | 3.79 |
Beta | 0.22 |
Volatility | 4.38% |
Current Volume | 0.7k |
Average Volume 20d | 2.9k |
As of March 15, 2025, the stock is trading at USD 26.75 with a total of 717 shares traded.
Over the past week, the price has changed by -0.65%, over one month by -0.70%, over three months by +0.99% and over the past year by +9.43%.
Partly, yes. Based on ValueRay Analyses, iShares U.S. Trust - (NYSE ARCA:HYGI) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 59.52 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HYGI as of March 2025 is 27.22. This means that HYGI is currently overvalued and has a potential downside of 1.76%.
iShares U.S. Trust - has no consensus analysts rating.
According to ValueRays Forecast Model, HYGI iShares U.S. Trust - will be worth about 29.6 in March 2026. The stock is currently trading at 26.75. This means that the stock has a potential upside of +10.77%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 29.6 | 10.8% |